Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Grace Therapeutics, Inc. - Common Stock (NQ: GRCE )

2.260 -0.040 (-1.74%)
Streaming Delayed Price Updated: 11:44 AM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,000
Open 2.290
Bid (Size) 2.250 (3)
Ask (Size) 2.260 (2)
Prev. Close 2.300
Today's Range 2.260 - 2.517
52wk Range 2.260 - 4.965
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
From Matinas BioPharma Holdings, Inc.
Via GlobeNewswire
Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study
Grace Therapeutics' GTx-104 met its Phase 3 trial endpoint, showing clinical benefits over oral nimodipine. US NDA submission is expected in early 2025. 
Via Benzinga

Performance

YTD
-43.50%
-43.50%
1 Month
-35.61%
-35.61%
3 Month
-43.36%
-43.36%
6 Month
-29.60%
-29.60%
1 Year
-29.60%
-29.60%
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.